Opportunistic screening for long-term muscle wasting in critically ill patients: insights from an acute pancreatitis cohort.


Journal

European journal of medical research
ISSN: 2047-783X
Titre abrégé: Eur J Med Res
Pays: England
ID NLM: 9517857

Informations de publication

Date de publication:
22 May 2024
Historique:
received: 04 03 2024
accepted: 13 05 2024
medline: 23 5 2024
pubmed: 23 5 2024
entrez: 22 5 2024
Statut: epublish

Résumé

To assess the feasibility of long-term muscle monitoring, we implemented an AI-guided segmentation approach on clinically indicated Computed Tomography (CT) examinations conducted throughout the hospitalization period of patients admitted to the intensive care unit (ICU) with acute pancreatitis (AP). In addition, we aimed to investigate the potential of muscle monitoring for early detection of patients at nutritional risk and those experiencing adverse outcomes. This cohort served as a model for potential integration into clinical practice. Retrospective cohort study including 100 patients suffering from AP that underwent a minimum of three CT scans during hospitalization, totaling 749 assessments. Sequential segmentation of psoas muscle area (PMA) was performed and was relative muscle loss per day for the entire monitoring period, as well as for the interval between each consecutive scan was calculated. Subgroup and outcome analyses were performed including ANOVA. Discriminatory power of muscle decay rates was evaluated using ROC analysis. Monitoring PMA decay revealed significant long-term losses of 48.20% throughout the hospitalization period, with an average daily decline of 0.98%. Loss rates diverged significantly between survival groups, with 1.34% PMA decay per day among non-survivors vs. 0.74% in survivors. Overweight patients exhibited significantly higher total PMA losses (52.53 vs. 42.91%; p = 0.02) and average PMA loss per day (of 1.13 vs. 0.80%; p = 0.039). The first and the maximum decay rate, in average available after 6.16 and 17.03 days after ICU admission, showed convincing discriminatory power for survival in ROC analysis (AUC 0.607 and 0.718). Both thresholds for maximum loss (at 3.23% decay per day) and for the initial loss rate (at 1.98% per day) proved to be significant predictors of mortality. The innovative AI-based PMA segmentation method proved robust and effortless, enabling the first comprehensive assessment of muscle wasting in a large cohort of intensive care pancreatitis patients. Findings revealed significant muscle wasting (48.20% on average), particularly notable in overweight individuals. Higher rates of initial and maximum muscle loss, detectable early, correlated strongly with survival. Integrating this tool into routine clinical practice will enable continuous muscle status tracking and early identification of those at risk for unfavorable outcomes.

Identifiants

pubmed: 38778361
doi: 10.1186/s40001-024-01884-7
pii: 10.1186/s40001-024-01884-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

294

Informations de copyright

© 2024. The Author(s).

Références

Bugiantella W, et al. Necrotizing pancreatitis: a review of the interventions. Int J Surg. 2016;28(Suppl 1):S163–71.
doi: 10.1016/j.ijsu.2015.12.038 pubmed: 26708848
Mederos MA, Reber HA, Girgis MD. Acute pancreatitis: a review. JAMA. 2021;325(4):382–90.
doi: 10.1001/jama.2020.20317 pubmed: 33496779
Teresi JA, et al. Guidelines for designing and evaluating feasibility pilot studies. Med Care. 2022;60(1):95–103.
doi: 10.1097/MLR.0000000000001664 pubmed: 34812790 pmcid: 8849521
Werner J, et al. Management of acute pancreatitis: from surgery to interventional intensive care. Gut. 2005;54(3):426–36.
doi: 10.1136/gut.2003.035907 pubmed: 15710995 pmcid: 1774421
Arvanitakis M, et al. ESPEN guideline on clinical nutrition in acute and chronic pancreatitis. Clin Nutr. 2020;39(3):612–31.
doi: 10.1016/j.clnu.2020.01.004 pubmed: 32008871
Le A, et al. Malnutrition imparts worse outcomes in patients admitted for acute pancreatitis. Cureus. 2023;15(3):e35822.
pubmed: 37033570 pmcid: 10075145
Fazzini B, et al. The rate and assessment of muscle wasting during critical illness: a systematic review and meta-analysis. Crit Care. 2023;27(1):2.
doi: 10.1186/s13054-022-04253-0 pubmed: 36597123 pmcid: 9808763
Busireddy KK, et al. Pancreatitis-imaging approach. World J Gastrointest Pathophysiol. 2014;5(3):252–70.
doi: 10.4291/wjgp.v5.i3.252 pubmed: 25133027 pmcid: 4133524
Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13(Suppl 1):S31–4.
doi: 10.4103/sja.SJA_543_18 pubmed: 30930717 pmcid: 6398292
Beetz NL, et al. Artificial intelligence-based analysis of body composition in Marfan: skeletal muscle density and psoas muscle index predict aortic enlargement. J Cachexia Sarcopenia Muscle. 2021;12(4):993–9.
doi: 10.1002/jcsm.12731 pubmed: 34137512 pmcid: 8350208
Kim D, et al. Comparative assessment of skeletal muscle mass using computerized tomography and bioelectrical impedance analysis in critically ill patients. Clin Nutr. 2019;38(6):2747–55.
doi: 10.1016/j.clnu.2018.12.002 pubmed: 30612851
Kolck J, et al. Intermittent body composition analysis as monitoring tool for muscle wasting in critically ill COVID-19 patients. Ann Intensive Care. 2023;13(1):61.
doi: 10.1186/s13613-023-01162-5 pubmed: 37421448 pmcid: 10329605
Derstine BA, et al. Skeletal muscle cutoff values for sarcopenia diagnosis using T10 to L5 measurements in a healthy US population. Sci Rep. 2018;8(1):11369.
doi: 10.1038/s41598-018-29825-5 pubmed: 30054580 pmcid: 6063941
Robert Koch-Institut (2022): Dashboard zu Gesundheit in Deutschland aktuell—GEDA 2019/2020.
Peterson SJ, Braunschweig CA. Prevalence of sarcopenia and associated outcomes in the clinical setting. Nutr Clin Pract. 2016;31(1):40–8.
doi: 10.1177/0884533615622537 pubmed: 26703961
Mayer KP, et al. Acute skeletal muscle wasting and dysfunction predict physical disability at hospital discharge in patients with critical illness. Crit Care. 2020;24(1):637.
doi: 10.1186/s13054-020-03355-x pubmed: 33148301 pmcid: 7640401
Tanaka K, Yamada T. Ultrasound measurement of septic shock-induced acute skeletal muscle atrophy in intensive care unit. PM R. 2021;13(4):347–52.
doi: 10.1002/pmrj.12406 pubmed: 32418351
Nakanishi N, et al. Monitoring of muscle mass in critically ill patients: comparison of ultrasound and two bioelectrical impedance analysis devices. J Intensive Care. 2019;7:61.
doi: 10.1186/s40560-019-0416-y pubmed: 31890223 pmcid: 6916000
Bunnell A, et al. Quantitative neuromuscular ultrasound in intensive care unit-acquired weakness: a systematic review. Muscle Nerve. 2015;52(5):701–8.
doi: 10.1002/mus.24728 pubmed: 26044880 pmcid: 4596754
Krishna SG, et al. Morbid obesity is associated with adverse clinical outcomes in acute pancreatitis: a propensity-matched study. Off J Am Coll Gastroenterol. 2015;110(11):1608–19.
doi: 10.1038/ajg.2015.343
Gullo L, et al. Acute pancreatitis in five European countries: etiology and mortality. Pancreas. 2002;24(3):223–7.
doi: 10.1097/00006676-200204000-00003 pubmed: 11893928
Lambden S, et al. The SOFA score-development, utility and challenges of accurate assessment in clinical trials. Crit Care. 2019;23(1):374.
doi: 10.1186/s13054-019-2663-7 pubmed: 31775846 pmcid: 6880479
Inoue S, et al. Post-intensive care syndrome: its pathophysiology, prevention, and future directions. Acute Med Surg. 2019;6(3):233–46.
doi: 10.1002/ams2.415 pubmed: 31304024 pmcid: 6603316
Adrion C, et al. Enhanced recovery after intensive care (ERIC): study protocol for a German stepped wedge cluster randomised controlled trial to evaluate the effectiveness of a critical care telehealth program on process quality and functional outcomes. BMJ Open. 2020;10(9):e036096.
doi: 10.1136/bmjopen-2019-036096 pubmed: 32978185 pmcid: 7520839
Vanhorebeek I, Latronico N, Van den Berghe G. ICU-acquired weakness. Intensive Care Med. 2020;46(4):637–53.
doi: 10.1007/s00134-020-05944-4 pubmed: 32076765 pmcid: 7224132
Hermans G, Van den Berghe G. Clinical review: intensive care unit acquired weakness. Crit Care. 2015;19:274.
doi: 10.1186/s13054-015-0993-7 pubmed: 26242743 pmcid: 4526175
Bruck E, et al. The impact of sepsis, delirium, and psychological distress on self-rated cognitive function in ICU survivors-a prospective cohort study. J Intensive Care. 2018;6:2.
doi: 10.1186/s40560-017-0272-6 pubmed: 29340154 pmcid: 5759266
Friedrich O, et al. The sick and the weak: neuropathies/myopathies in the critically Ill. Physiol Rev. 2015;95(3):1025–109.
doi: 10.1152/physrev.00028.2014 pubmed: 26133937 pmcid: 4491544

Auteurs

Johannes Kolck (J)

Department of Radiology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. Johannes.kolck@charite.de.

Clarissa Hosse (C)

Department of Radiology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.

Alexandra Leimbach (A)

Department of Anesthesiology and Intensive Care Medicine | CCM | CVK, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Nick L Beetz (NL)

Department of Radiology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.

Timo A Auer (TA)

Department of Radiology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.

Federico Collettini (F)

Department of Radiology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.

Uli Fehrenbach (U)

Department of Radiology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.

Christian Pille (C)

Department of Anesthesiology and Intensive Care Medicine | CCM | CVK, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Dominik Geisel (D)

Department of Radiology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH